← Back to Clinical Trials
Recruiting Phase 3 NCT06810375
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
Trial Parameters
Condition Lung Cancers
Sponsor George Washington University
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 120
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2025-03-01
Completion 2028-02-28
Interventions
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)Intercostal nerve block
Brief Summary
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
Eligibility Criteria
Inclusion Criteria: * Video assisted pulmonary resection, pleurodesis or decortication Exclusion Criteria: * Allergy to local anesthetics * Patient undergoing bilateral surgery * Surgery is emergent as deemed by the principal investigator